44 related articles for article (PubMed ID: 34534137)
1. Histotype classification of ovarian carcinoma: A comparison of approaches.
Peres LC; Cushing-Haugen KL; Anglesio M; Wicklund K; Bentley R; Berchuck A; Kelemen LE; Nazeran TM; Gilks CB; Harris HR; Huntsman DG; Schildkraut JM; Rossing MA; Köbel M; Doherty JA
Gynecol Oncol; 2018 Oct; 151(1):53-60. PubMed ID: 30121132
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of initial symptoms in endometriosis-associated ovarian cancer.
Ono M; Fukuda M; Yamanoi K; Sunada M; Kitamura S; Taki M; Horie A; Yamaguchi K; Hamanishi J; Mandai M
Turk J Obstet Gynecol; 2024 Mar; 21(1):28-36. PubMed ID: 38440965
[TBL] [Abstract][Full Text] [Related]
3. Shared genetics underlying epidemiological association between endometriosis and ovarian cancer.
Lu Y; Cuellar-Partida G; Painter JN; Nyholt DR; ; ; Morris AP; Fasching PA; Hein A; Burghaus S; Beckmann MW; Lambrechts D; Van Nieuwenhuysen E; Vergote I; Vanderstichele A; Doherty JA; Rossing MA; Wicklund KG; Chang-Claude J; Eilber U; Rudolph A; Wang-Gohrke S; Goodman MT; Bogdanova N; Dörk T; Dürst M; Hillemanns P; Runnebaum IB; Antonenkova N; Butzow R; Leminen A; Nevanlinna H; Pelttari LM; Edwards RP; Kelley JL; Modugno F; Moysich KB; Ness RB; Cannioto R; Høgdall E; Jensen A; Giles GG; Bruinsma F; Kjaer SK; Hildebrandt MA; Liang D; Lu KH; Wu X; Bisogna M; Dao F; Levine DA; Cramer DW; Terry KL; Tworoger SS; Missmer S; Bjorge L; Salvesen HB; Kopperud RK; Bischof K; Aben KK; Kiemeney LA; Massuger LF; Brooks-Wilson A; Olson SH; McGuire V; Rothstein JH; Sieh W; Whittemore AS; Cook LS; Le ND; Gilks CB; Gronwald J; Jakubowska A; Lubiński J; Gawełko J; Song H; Tyrer JP; Wentzensen N; Brinton L; Trabert B; Lissowska J; Mclaughlin JR; Narod SA; Phelan C; Anton-Culver H; Ziogas A; Eccles D; Gayther SA; Gentry-Maharaj A; Menon U; Ramus SJ; Wu AH; Dansonka-Mieszkowska A; Kupryjanczyk J; Timorek A; Szafron L; Cunningham JM; Fridley BL; Winham SJ; Bandera EV; Poole EM; Morgan TK; Risch HA; Goode EL; Schildkraut JM; Webb PM; Pearce CL; Berchuck A; Pharoah PD; Montgomery GW; Zondervan KT; Chenevix-Trench G; MacGregor S
Hum Mol Genet; 2015 Oct; 24(20):5955-64. PubMed ID: 26231222
[TBL] [Abstract][Full Text] [Related]
4. Validation of Novel Prognostic Biomarkers for Early-Stage Clear-Cell, Endometrioid and Mucinous Ovarian Carcinomas Using Immunohistochemistry.
Engqvist H; Parris TZ; Kovács A; Rönnerman EW; Sundfeldt K; Karlsson P; Helou K
Front Oncol; 2020; 10():162. PubMed ID: 32133296
[TBL] [Abstract][Full Text] [Related]
5. Reliable Identification of Endometrial Precancers Through Combined Pax2, β-Catenin, and Pten Immunohistochemistry.
Aguilar M; Chen H; Rivera-Colon G; Niu S; Carrick K; Gwin K; Cuevas IC; Sahoo SS; Li HD; Zhang S; Zheng W; Lucas E; Castrillon DH
Am J Surg Pathol; 2022 Mar; 46(3):404-414. PubMed ID: 34545858
[TBL] [Abstract][Full Text] [Related]
6. Early Detection of Molecular Residual Disease and Risk Stratification for Stage I to III Colorectal Cancer via Circulating Tumor DNA Methylation.
Mo S; Ye L; Wang D; Han L; Zhou S; Wang H; Dai W; Wang Y; Luo W; Wang R; Xu Y; Cai S; Liu R; Wang Z; Cai G
JAMA Oncol; 2023 Jun; 9(6):770-778. PubMed ID: 37079312
[TBL] [Abstract][Full Text] [Related]
7. Selection of endometrial carcinomas for p53 immunohistochemistry based on nuclear features.
Kang EY; Wiebe NJ; Aubrey C; Lee CH; Anglesio MS; Tilley D; Ghatage P; Nelson GS; Lee S; Köbel M
J Pathol Clin Res; 2022 Jan; 8(1):19-32. PubMed ID: 34596362
[TBL] [Abstract][Full Text] [Related]
8. Mucin Neovascularization as a Diagnostic Aid to Distinguish Mucinous Carcinomas From Mucocele-like Lesions in Breast Core Needle Biopsies.
Onken AM; Collins LC; Schnitt SJ
Am J Surg Pathol; 2022 May; 46(5):637-642. PubMed ID: 34545857
[TBL] [Abstract][Full Text] [Related]
9. Tryptophan metabolism enzymes are potential targets in ovarian clear cell carcinoma.
Zhang S; Gao Y; Wang P; Wang S; Wang Y; Li M; Wang A; Zhao K; Zhang Z; Sun J; Guo D; Liang Z
Cancer Med; 2023 Dec; 12(24):21996-22005. PubMed ID: 38062922
[TBL] [Abstract][Full Text] [Related]
10. p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study.
Köbel M; Kang EY; Weir A; Rambau PF; Lee CH; Nelson GS; Ghatage P; Meagher NS; Riggan MJ; Alsop J; Anglesio MS; Beckmann MW; Bisinotto C; Boisen M; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; Deen S; El-Bahrawy MA; Elishaev E; Erber R; Fereday S; ; Fischer A; Gayther SA; Barquin-Garcia A; Gentry-Maharaj A; Gilks CB; Gronwald H; Grube M; Harnett PR; Harris HR; Hartkopf AD; Hartmann A; Hein A; Hendley J; Hernandez BY; Huang Y; Jakubowska A; Jimenez-Linan M; Jones ME; Kennedy CJ; Kluz T; Koziak JM; Lesnock J; Lester J; Lubiński J; Longacre TA; Lycke M; Mateoiu C; McCauley BM; McGuire V; Ney B; Olawaiye A; Orsulic S; Osorio A; Paz-Ares L; Ramón Y Cajal T; Rothstein JH; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Singh N; Steed H; Storr SJ; Talhouk A; Traficante N; Wang C; Whittemore AS; Widschwendter M; Wilkens LR; Winham SJ; Benitez J; Berchuck A; Bowtell DD; Candido Dos Reis FJ; Campbell I; Cook LS; DeFazio A; Doherty JA; Fasching PA; Fortner RT; García MJ; Goodman MT; Goode EL; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Kommoss S; Le ND; Martin SG; Menon U; Modugno F; Pharoah PD; Schildkraut JM; Sieh W; Staebler A; Sundfeldt K; Swerdlow AJ; Ramus SJ; Brenton JD
J Pathol Clin Res; 2023 May; 9(3):208-222. PubMed ID: 36948887
[TBL] [Abstract][Full Text] [Related]
11. The Evolution of Ovarian Carcinoma Subclassification.
Köbel M; Kang EY
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053578
[TBL] [Abstract][Full Text] [Related]
12. Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8
Heinze K; Nazeran TM; Lee S; Krämer P; Cairns ES; Chiu DS; Leung SC; Kang EY; Meagher NS; Kennedy CJ; Boros J; Kommoss F; Vollert HW; Heitz F; du Bois A; Harter P; Grube M; Kraemer B; Staebler A; Kommoss FK; Heublein S; Sinn HP; Singh N; Laslavic A; Elishaev E; Olawaiye A; Moysich K; Modugno F; Sharma R; Brand AH; Harnett PR; DeFazio A; Fortner RT; Lubinski J; Lener M; Tołoczko-Grabarek A; Cybulski C; Gronwald H; Gronwald J; Coulson P; El-Bahrawy MA; Jones ME; Schoemaker MJ; Swerdlow AJ; Gorringe KL; Campbell I; Cook L; Gayther SA; Carney ME; Shvetsov YB; Hernandez BY; Wilkens LR; Goodman MT; Mateoiu C; Linder A; Sundfeldt K; Kelemen LE; Gentry-Maharaj A; Widschwendter M; Menon U; Bolton KL; Alsop J; Shah M; Jimenez-Linan M; Pharoah PD; Brenton JD; Cushing-Haugen KL; Harris HR; Doherty JA; Gilks B; Ghatage P; Huntsman DG; Nelson GS; Tinker AV; Lee CH; Goode EL; Nelson BH; Ramus SJ; Kommoss S; Talhouk A; Köbel M; Anglesio MS
J Pathol; 2022 Apr; 256(4):388-401. PubMed ID: 34897700
[TBL] [Abstract][Full Text] [Related]
13. Accurate Distinction of Ovarian Clear Cell From Endometrioid Carcinoma Requires Integration of Phenotype, Immunohistochemical Predictions, and Genotype: Implications for Lynch Syndrome Screening.
Rodriguez M; Kang EY; Farrington K; Cook LS; Le ND; Karnezis AN; Lee CH; Nelson GS; Terzic T; Lee S; Köbel M
Am J Surg Pathol; 2021 Nov; 45(11):1452-1463. PubMed ID: 34534137
[TBL] [Abstract][Full Text] [Related]
14. The histomorphology of Lynch syndrome-associated ovarian carcinomas: toward a subtype-specific screening strategy.
Chui MH; Ryan P; Radigan J; Ferguson SE; Pollett A; Aronson M; Semotiuk K; Holter S; Sy K; Kwon JS; Soma A; Singh N; Gallinger S; Shaw P; Arseneau J; Foulkes WD; Gilks CB; Clarke BA
Am J Surg Pathol; 2014 Sep; 38(9):1173-81. PubMed ID: 25025451
[TBL] [Abstract][Full Text] [Related]
15. Morphologic Reproducibility, Genotyping, and Immunohistochemical Profiling Do Not Support a Category of Seromucinous Carcinoma of the Ovary.
Rambau PF; McIntyre JB; Taylor J; Lee S; Ogilvie T; Sienko A; Morris D; Duggan MA; McCluggage WG; Köbel M
Am J Surg Pathol; 2017 May; 41(5):685-695. PubMed ID: 28125452
[TBL] [Abstract][Full Text] [Related]
16. Mismatch-repair deficiency, microsatellite instability, and lynch syndrome in ovarian cancer: A systematic review and meta-analysis.
Mitric C; Salman L; Abrahamyan L; Kim SR; Pechlivanoglou P; Chan KKW; Gien LT; Ferguson SE
Gynecol Oncol; 2023 Mar; 170():133-142. PubMed ID: 36682091
[TBL] [Abstract][Full Text] [Related]
17. Mismatch Repair Deficiency in Ovarian Carcinoma: Frequency, Causes, and Consequences.
Leskela S; Romero I; Cristobal E; Pérez-Mies B; Rosa-Rosa JM; Gutierrez-Pecharroman A; Caniego-Casas T; Santón A; Ojeda B; López-Reig R; Palacios-Berraquero ML; García Á; Ibarra J; Hakim S; Guarch R; López-Guerrero JA; Poveda A; Palacios J
Am J Surg Pathol; 2020 May; 44(5):649-656. PubMed ID: 32294063
[TBL] [Abstract][Full Text] [Related]
18. Morphologic, Immunophenotypic, and Molecular Features of Epithelial Ovarian Cancer.
Ramalingam P
Oncology (Williston Park); 2016 Feb; 30(2):166-76. PubMed ID: 26892153
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]